Ancillary benefits of prenatal maternal serum screening achieved in the California program

Prenatal Diagnosis

Volumn 30, Issue 10, 2010, Pages 981-987

  Kazerouni, N Neely ^a   Currier, Robert J ^a   Hodgkinson, Christina ^a   Goldman, Sara ^a   Lorey, Fred ^a   Roberson, Marie ^a  

^a CALIFORNIA DEPARTMENT OF PUBLIC HEALTH   (United States)

Author keywords

Fetal structural abnormalities; Nueral tube defects; Quad marker screening; Smith Lemli Opitz syndrome; Trisomy 21; Ultrasound

Indexed keywords

ABDOMINAL WALL DEFECT; ADULT; ARTICLE; FEMALE; FETUS; FETUS DISEASE; FETUS ECHOGRAPHY; FOLLOW UP; HEALTH PROGRAM; HUMAN; HYDATIDIFORM MOLE; MAJOR CLINICAL STUDY; MATERNAL SERUM; NEURAL TUBE DEFECT; PRENATAL SCREENING; PRIORITY JOURNAL; SMITH LEMLI OPITZ SYNDROME; TRISOMY 18; TRISOMY 21; TWIN TWIN TRANSFUSION SYNDROME; UNITED STATES;

ADULT; BIOLOGICAL MARKERS; CALIFORNIA; CONGENITAL ABNORMALITIES; FEMALE; HUMANS; MASS SCREENING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL DIAGNOSIS; VOLUNTARY PROGRAMS;

EID: 77957342576     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2601     Document Type: Article

References (24)

1. ACOG Committee on Practice Bulletins. 2009. ACOG Practice Bulletin No. 101: Ultrasonography in pregnancy. Obstet Gynecol 113: 451-461.
2. American College of Radiology. 2007. ACR practice guideline for the performance of obstetrical ultrasound. Reston (VA): American College of Radiology. http://www.acr.org/SecondaryMainMenuCategories/quality-safety/ guidelines/us/us-obstetrical.aspx [Retrieved 15 December 2009].
3. American Institute of Ultrasound in Medicine. 2007. AIUM practice guideline for the performance of obstetric ultrasound examinations. Laurel (MD): American Institute of Ultrasound in Medicine. http://www.aium.org/publications/ guidelines/obstetric.pdf [Retrieved 15 December 2009].
4. Boyd PA, Chamberlain P, Hicks NR. 1998. 6-year experience of prenatal diagnosis in an unselected population in Oxford, UK. Lancet 352(9140): 1577-1581.
5. Bricker L, Garcia J, Henderson J, et al. 2000. Ultrasound screening in pregnancy: a systematic review of the clinical effectiveness, costeffectiveness and women's views. Health Technol Assess 4(16):1-193.
6. California Code of Regulations. 1986. California Administrative Code Title 17, Section 6532. http://ccr.oal.ca.gov/linkedslice/default.asp?SP=CCR- 1000&Action=Welcome [Retrieved 09 January 2009].
7. Celentano C, Guanciali-Franchi PE, Liberati M, et al. 2005. Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomaly. Prenat Diagn 25: 220-224.
8. Chitty LS, Hunt GH, Moore J, Lobb MO. 1991. Effectiveness of routine ultrasonography in detecting fetal structural abnormalities in a low risk population. BMJ 303(6811): 1165-1169.
9. Craig WY, Haddow JE, Palomaki GE, Roberson M. 2007. Major fetal abnormalities associated with positive screening tests for SLOS. Prenat Diagn 27: 409-414.
10. Crane JP, LeFevre ML, Winborn RC, et al. 1994. A randomized trial of prenatal ultrasonographic screening: impact on the detection, management, and outcome of anomalous fetuses. The RADIUS Study Group. Am J Obstet Gynecol 171(2): 392-399.
11. Cunningham GC, Tompkinson DG. 1999. Cost and effectiveness of the California triple marker prenatal screening program. Genetics in Medicine 1: 199-206.
12. Fejgin MD, Kedar I, Amiel A, et al. 1997. Elevated hCG as an isolated finding during the second trimester biochemical screen: genetic, ultrasonic, and perinatal significance. Prenat Diagn 17: 1027-1031.
13. Hoffman JD, Bianchi DW, Sullivan LM, et al. 2008. Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two-vessel cord, and hydrocele. Prenat Diagn 28: 1204-1208.
14. Jelliffe-Pawlowski LL, Walton-Haynes L, Currier RJ. 2009. Identification of second trimester screen positive pregnancies at increased risk for congenital heart defects. Prenat Diagn 29: 570-577.
15. Kazerouni NN, Currier B, Malm L, et al. 2009. Triple-marker prenatal screening program for chromosomal defects. Obstet Gynecol 114: 50-58.
16. Lee K, Kim SY, Choi SM, et al. 1998. Effectiveness of prenatal ultrasonography in detecting fetal anomalies and perinatal outcome of anomalous fetuses. Yonsei Med J 39(4): 372-382.
17. Levi S, Hyjazi Y, Schaapst JP, et al. 1991. Sensitivity and specificity of routine antenatal screening for congenital anomalies by ultrasound: the Belgian Multicentric Study. Ultrasound Obstet Gynecol 1(2): 102-110.
18. Levi S, Schaaps JP, De Havay P, et al. 1995. End-result of routine ultrasound screening for congenital anomalies: the Belgian Multicentric Study 1984-92. Ultrasound Obstet Gynecol 5(6): 366-371.
19. Luck CA. 1992. Value of routine ultrasound scanning at 19 weeks: a four year study of 8849 deliveries. BMJ 304(6840): 1474-1478.
20. Magriples U, Copel JA. 1998. Accurate detection of anomalies by routine ultrasonography in an indigent clinic population. Am J Obstet Gynecol 179(4): 978-981.
21. Shirley IM, Bottomley F, Robinson VP. 1992. Routine radiographer screening for fetal abnormalities by ultrasound in an unselected low risk population. Br J Radiol 65(775): 564-569.
22. Skupski DW, Newman S, Edersheim T, et al. 1996. The impact of routine obstetric ultrasonographic screening in a low-risk population. Am J Obstet Gynecol 175(5): 1142-1145.
23. United States Census Bureau. 2006-2008. American Community Survey 3-Year Estimates, Table: B03001 Hispanic or Latino Origin by Specific Origin. http://factfinder.census.gov/servlet/DTTable?bm=y&-context=dt&-ds name=ACS 2008 3YR G00 &-CONTEXT=dt&-mt name=ACS 2008 3YR G2000 B03001&-tree id=306&-redoLog=false&-geo id=04000US06&-search results=01000US&-format=. [Retrieved 15 December 2009].
24. VanDorsten JP, Hulsey TC, Newman RB, Menard MK. 1998. Fetal anomaly detection by second-trimester ultrasonography in a tertiary center. Am J Obstet Gynecol 178(4): 742-749.